Tocagen Inc.
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8) (NCT04089163) | Tocagen Inc. | 2019-12-01 |
Track Tocagen Inc. automatically
Every clearance here is in the API, with alerts when new ones post.